Stock comparison
Alignment Healthcare
LeMaitre Vascular
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
ALHC
Alignment Healthcare
Market cap
$3.38B
Sector
Healthcare
LMAT
LeMaitre Vascular
Market cap
$2.23B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | ALHC | LMAT | Winner |
|---|---|---|---|
| Warren Buffett | 34F | 77B | LMAT |
| Benjamin Graham | 68D | 89A | LMAT |
| Philip Fisher | 46D | 81C | LMAT |
| Peter Lynch | 66B | 67B | LMAT |
| Joel Greenblatt | 43D | 56D | LMAT |
| Charlie Munger | 36D | 68D | LMAT |
| Terry Smith | 33F | 69D | LMAT |
Side-by-side metrics
| Metric | ALHC | LMAT |
|---|---|---|
| Market cap | $3.38B | $2.23B |
| P/E (TTM) | 186.4x | 37.1x |
| EV/EBIT | 178.7x | 36.6x |
| ROIC (TTM) | 5.88% | 9.43% |
| Gross margin | 12.38% | 72.39% |
| Net margin | 0.47% | 24.35% |
| Revenue CAGR 5y | 35.6% | 12.75% |
| EPS CAGR 5y | - | 19.04% |
| Debt / Equity | 1.6x | 0.5x |
| Dividend yield | 0.0% | 0.84% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ALHC leads on
- Revenue CAGR 5y35.6%vs 12.75%+64%
- Market cap$3.38Bvs $2.23B+34%
LMAT leads on
- Dividend yield0.84%vs 0.0%+100%
- Net margin24.35%vs 0.47%+98%
- Gross margin72.39%vs 12.38%+83%
- P/E (TTM)37.1xvs 186.4x+80%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.